Vancouver, BC, November 28, 2023--AbCellera presented new data on its T-cell engager (TCE) programs in two poster presentations at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting.
AbCellera
Vancouver (Biotech/Life Sciences) 100-499 Employees In BC (100-499 Employees Total)
Founded: 2012
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease.
Vancouver, BC, November 6, 2023--AbCellera and Prelude Therapeutics announced a multi-year, multi-program partnership to discover, develop, and commercialize potentially first-in-class treatments for patients with cancer.
AbCellera
Vancouver (Biotech/Life Sciences) 100-499 Employees In BC (100-499 Employees Total)
Founded: 2012
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease.
Vancouver, BC, November 3, 2023--AbCellera announced financial results for the third quarter of 2023. The company earned $6.6 million in total revenue and generated a net loss of $28.6 million, compared to total revenue of $101 million and net earnings of $26.6 million in Q3 2022.
AbCellera
Vancouver (Biotech/Life Sciences) 100-499 Employees In BC (100-499 Employees Total)
Founded: 2012
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease.
Vancouver, BC, September 26, 2023--AbCellera announced that it has expanded its existing multi-target collaboration with Regeneron to discover therapeutic antibodies for up to eight targets selected by Regeneron, increased from the original four.
AbCellera
Vancouver (Biotech/Life Sciences) 100-499 Employees In BC (100-499 Employees Total)
Founded: 2012
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease.
Vancouver, BC, September 19, 2023--AbCellera announced that it has entered into a strategic collaboration with Incyte to discover and develop therapeutic antibodies in oncology.
AbCellera
Vancouver (Biotech/Life Sciences) 100-499 Employees In BC (100-499 Employees Total)
Founded: 2012
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease.
Vancouver, BC, August 4, 2023--AbCellera announced financial results for the second quarter of 2023. The company earned $10.1 million in total revenue and generated a net loss of $30.5 million, compared to a net loss of $6.8 million in Q2 2022. The company maintained a cumulative total of 177 programs under contract with 41 different partners.
AbCellera
Vancouver (Biotech/Life Sciences) 100-499 Employees In BC (100-499 Employees Total)
Founded: 2012
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease.
Vancouver, BC, July 24, 2023--AbCellera announced that the United States Patent and Trademark Office's (USPTO) Patent Trial and Appeal Board (PTAB) has denied a rehearing request in an Inter Partes Review (IPR) filed by Berkeley Lights, Inc. (Berkeley Lights) that challenged AbCellera's U.S. Patent No. 10,087,408 (the '408 Patent).
AbCellera
Vancouver (Biotech/Life Sciences) 100-499 Employees In BC (100-499 Employees Total)
Founded: 2012
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease.
Vancouver, BC, May 9, 2023--AbCellera announced financial results for the first quarter of 2023. The company reported total revenue of US $12 million, compared to US $317 million in Q1 2022, and generated a net loss of US $40.1 million.
AbCellera
Vancouver (Biotech/Life Sciences) 100-499 Employees In BC (100-499 Employees Total)
Founded: 2012
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease.
Vancouver, BC, March 23, 2023--AbCellera and RQ Bio announced that they have entered into a strategic collaboration to identify optimal clinical candidates for up to three infectious disease targets selected by RQ Bio, including influenza and cytomegalovirus (CMV).
AbCellera
Vancouver (Biotech/Life Sciences) 100-499 Employees In BC (100-499 Employees Total)
Founded: 2012
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease.
Vancouver, BC, February 22, 2023--AbCellera announced financial results for the full year 2022. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated.
AbCellera
Vancouver (Biotech/Life Sciences) 100-499 Employees In BC (100-499 Employees Total)
Founded: 2012
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease.